-
公开(公告)号：EP2855451A1
公开(公告)日：2015-04-08
申请号：EP13724816.7
申请日：2013-05-23
申请人： Cellzome Limited
发明人： HARRISON, Richard John , RAMSDEN, Nigel , MAJOR, Jeremy , MOREL, Adeline , CONVERY, Laura , SUNOSE, Mihiro , LYNCH, Rosemary , ADREGO, Rita , JONES, Alison
IPC分类号： C07D401/14 , C07D403/12 , C07D405/14 , C07D413/14 , A61K31/505 , A61P37/00
CPC分类号： A61K31/506 , A61K31/505 , A61K31/5377 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D407/14 , C07D413/14 , C07D417/14 , C07D471/08 , C07D487/10 , C07D491/048 , C07D491/107
摘要： The present invention relates to compounds of formula (I), wherein R, R
1 , X
1 to X
5 have the meaning as cited in the description and the claims. Said compounds are useful as TYK2 inhibitors for the treatment or prophylaxis of immunological, inflammatory, autoimmune, allergic disorders, and immunologically-mediated diseases. The invention also relates to pharmaceutical compositions including said compounds as well as their use as medicaments.摘要翻译： 本发明涉及式（I）化合物，其中R 1，R 1，X 1至X 5具有在说明书和权利要求书中引用的含义。 所述化合物可用作治疗或预防免疫学，炎性，自身免疫性，过敏性疾病和免疫介导的疾病的TYK2抑制剂。 本发明还涉及包含所述化合物的药物组合物以及它们作为药物的用途。
-
2.发明公开MORPHOLINO SUBSTITUTED UREA OR CARBAMATE DERIVATIVES AS MTOR INHIBITORS 有权2-吗啉代-1,3,5-三嗪的尿素和氨基甲酸酯衍生物作为mTOR抑制剂用于免疫学或增殖性疾病的治疗
公开(公告)号：EP2758379A1
公开(公告)日：2014-07-30
申请号：EP12761738.9
申请日：2012-09-21
申请人： Cellzome Limited
发明人： LYNCH, Rosemary , CANSFIELD, Andrew David , HARDY, Daniel Paul , SUNOSE, Mihiro , MOREL, Adeline , CONVERY, Laura , ADREGO, Rita
IPC分类号： C07D251/22 , C07D401/12 , C07D407/12 , C07D413/04 , A61K31/53 , A61P37/02 , A61P37/04 , A61P37/06 , A61P37/08 , A61P35/00
CPC分类号： C07D498/08 , C07D251/22 , C07D401/12 , C07D407/12 , C07D413/04 , C07D413/14
摘要： The invention relates to compounds of formula (I), wherein m, n, R
1 , T
0 and T
1 have the meaning as cited in the description and the claims. Said compounds are useful as inhibitors of mTOR for the treatment or prophylaxis of mTOR related diseases and disorders. The invention also relates to pharmaceutical compositions including said compounds as well as the use as medicaments.-
公开(公告)号：EP2855451B1
公开(公告)日：2017-10-04
申请号：EP13724816.7
申请日：2013-05-23
申请人： Cellzome Limited
发明人： HARRISON, Richard John , RAMSDEN, Nigel , MAJOR, Jeremy , MOREL, Adeline , CONVERY, Laura , SUNOSE, Mihiro , LYNCH, Rosemary , ADREGO, Rita , JONES, Alison
IPC分类号： C07D401/14 , C07D403/12 , C07D405/14 , C07D413/14 , A61K31/505 , A61P37/00
CPC分类号： A61K31/506 , A61K31/505 , A61K31/5377 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D407/14 , C07D413/14 , C07D417/14 , C07D471/08 , C07D487/10 , C07D491/048 , C07D491/107
-
4.发明授权Urea and carbamate derivatives of 2-morpholino-1,3,5-triazine as mTOR inhibitors for the treatment of immunological or proliferative diseases 有权2-吗啉代-1,3,5-三嗪的尿素和氨基甲酸酯衍生物作为mTOR抑制剂用于免疫学或增殖性疾病的治疗
公开(公告)号：EP2758379B1
公开(公告)日：2016-10-19
申请号：EP12761738.9
申请日：2012-09-21
申请人： Cellzome Limited
发明人： LYNCH, Rosemary , CANSFIELD, Andrew David , HARDY, Daniel Paul , SUNOSE, Mihiro , MOREL, Adeline , CONVERY, Laura , ADREGO, Rita
IPC分类号： C07D251/22 , C07D401/12 , C07D407/12 , C07D413/04 , A61K31/53 , A61P37/02 , A61P37/04 , A61P37/06 , A61P37/08 , A61P35/00
CPC分类号： C07D498/08 , C07D251/22 , C07D401/12 , C07D407/12 , C07D413/04 , C07D413/14
-
-
-
搜索结果
4 条记录 (耗时 0.026 秒)
